| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/20/2013 | WO2013087936A1 Combination of a prostaglandin receptor agonist and an mc1r receptor agonist for the treatment and/or prevention of pigmentation disorders |
| 06/20/2013 | WO2013087914A1 EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED |
| 06/20/2013 | WO2013087913A1 Compounds and methods for treating inflammatory diseases |
| 06/20/2013 | WO2013087912A1 Compounds and methods for treating inflammatory diseases |
| 06/20/2013 | WO2013087911A1 Compounds and methods for treating inflammatory diseases |
| 06/20/2013 | WO2013087767A1 Compositions for enhancing skin antimicrobial defence |
| 06/20/2013 | WO2013087004A1 Imidazolidinedione compounds and their uses |
| 06/20/2013 | WO2013073968A3 Agents for modulation of cell signalling |
| 06/20/2013 | WO2013062266A3 Wrap fermentation method using a medicinal flower, and composition for external application onto the skin using same |
| 06/20/2013 | WO2013050529A3 Use of igf-1 in the stimulation of treg cell activity and the treatment autoimmune disorders |
| 06/20/2013 | WO2012068299A9 Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells |
| 06/20/2013 | US20130158502 Method of inhibiting angiogenesis or invasion or formation of metastases |
| 06/20/2013 | US20130158234 Specific binding agents of human angiopoietin-2 |
| 06/20/2013 | US20130158129 Natural, multiple release and re-use compositions |
| 06/20/2013 | US20130156855 Acne treatment |
| 06/20/2013 | US20130156712 Stable surfactant compositions for suspending components |
| 06/20/2013 | US20130156696 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 06/20/2013 | US20130156695 Use of zcytor17 ligand antagonists for treating inflammatory diseases |
| 06/20/2013 | DE102006044448B4 Gelartiges Basenpräparat zur Supplementierung von Spurenelementen und Verfahren zu dessen Herstellung Gel-base preparation for supplementation of trace elements and process for its production |
| 06/19/2013 | EP2604605A2 Theanine derivative, preparation method thereof, and use thereof for alleviating acne |
| 06/19/2013 | EP2604601A1 Hetero ring compound |
| 06/19/2013 | EP2604261A2 SCCA-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient |
| 06/19/2013 | EP2604254A1 Slimming composition |
| 06/19/2013 | CN203001479U Cetirizine hydrochloride tablet |
| 06/19/2013 | CN103167894A Inhibition of microbial growth by aconitase inhibition |
| 06/19/2013 | CN103167865A Collagen production promoter, hyaluronan production promoter, fibroblast proliferation promoter, and anti-wrinkle agent |
| 06/19/2013 | CN103160488A Antarctic ice algae CPD photolyase, and coding gene, expression vector and application thereof |
| 06/19/2013 | CN103159851A Micromolecule polypeptide preventing and restraining inflammation and application thereof |
| 06/19/2013 | CN103159788A Condensed imidazole formamide serving as transient receptor potential vanillin 3 (TRPV3) modifier |
| 06/19/2013 | CN103159736A Substitutional pyrazol kinase inhibitor |
| 06/19/2013 | CN103159735A Substitutional imidazole kinase inhibitor |
| 06/19/2013 | CN103159726A Chromene ketone derivative used as transient receptor potential vanillin3 (TRPV3) antagonist |
| 06/19/2013 | CN103159680A Imidazole diketone compound and application thereof |
| 06/19/2013 | CN103157091A Drug for treating empyrosis |
| 06/19/2013 | CN103157082A Medicament for treating herpes zoster |
| 06/19/2013 | CN103157079A Plant soaking lotion used for preventing losing hair and promoting growing hair and preparation and use method thereof |
| 06/19/2013 | CN103157071A Chinese herbal compound film for treating dermatomycosis and preparation method thereof |
| 06/19/2013 | CN103157050A Traditional Chinese medicine composition for treating vulvar itching diseases and preparation method thereof |
| 06/19/2013 | CN103157047A Traditional chinese medicine for treating eczema |
| 06/19/2013 | CN103157009A Medicament for treating long-term unhealed wounds even if snake venom has been detoxified |
| 06/19/2013 | CN103157004A Traditional Chinese medicine for treating white hairs |
| 06/19/2013 | CN103156979A Beverage-removing and whitening medicine |
| 06/19/2013 | CN103156966A Female natural pudenda protection health liquid |
| 06/19/2013 | CN103156959A Medicament for treating varicella |
| 06/19/2013 | CN103156845A Compounds having immunomodulator activity |
| 06/19/2013 | CN103156843A Composition for whitening and removing freckles and preparation thereof |
| 06/19/2013 | CN103156815A Dispersible tablet used for white ringworm and preparation method thereof |
| 06/19/2013 | CN103156785A Formula of acne removal essential oil |
| 06/19/2013 | CN103156729A Wound medicine patch |
| 06/19/2013 | CN102631423B Care solution for wound cleaning |
| 06/19/2013 | CN102626473B Traditional Chinese medicine for treating traumatic injury, internal ulcer and external ulcer |
| 06/19/2013 | CN102600185B External preparation used for treating infectious skin diseases |
| 06/19/2013 | CN102526331B Traditional Chinese medicinal abrasive cleaner for treating diaper dermatitis in clinical care |
| 06/19/2013 | CN102416054B Composition for treating onychomycosis and tinea manus and pedis |
| 06/19/2013 | CN102357145B Externally applied ointment for treating baldness |
| 06/19/2013 | CN102335328B Chinese medicine oral preparation for hair growth and hair blackening |
| 06/19/2013 | CN102302637B Plaster for treating chilblain and preparation method thereof |
| 06/19/2013 | CN102293863B Medicine capable of strengthening physical health, promoting regrowth of hair and turning white hair into black hair |
| 06/19/2013 | CN102178956B Preparation, medical application and composition of 20S-protopanaxadiol beta-cyclodextrin inclusion compound |
| 06/19/2013 | CN101938988B Skin whitening agent and external preparation for the skin |
| 06/19/2013 | CN101914168B Medical applications and preparation methods of Pleurotus ferulae Lanzi polysaccharide and composites thereof |
| 06/19/2013 | CN101766546B Association of monosaccharides and C-glycoside derivatives and its use in cosmetics |
| 06/19/2013 | CN101757013B Hair-growing agent composition |
| 06/19/2013 | CN101594871B Pyrrolopyrimidine compounds and their uses |
| 06/19/2013 | CN101486701B Analogue compound, and analogue and medical use thereof |
| 06/19/2013 | CN101486700B 8-acetyl chromanone compound, and analogue and medical use thereof |
| 06/19/2013 | CN101457145B Antioxidant and antioxidant cosmetic |
| 06/19/2013 | CN101390815B Topical use of thiazolidine derivatives against the consequences of oxidising stress of the skin |
| 06/19/2013 | CN101233155B 人抗表皮生长因子受体抗体 Human anti-epidermal growth factor receptor antibody |
| 06/18/2013 | USRE44302 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use |
| 06/18/2013 | US8466172 Stabilization of hypoxia inducible factor (HIF) alpha |
| 06/18/2013 | US8466112 Compositions comprising Ornithine Ketoglutarate (OKG) |
| 06/18/2013 | US8466102 Antimicrobial cationic peptides and formulations thereof |
| 06/18/2013 | CA2267077C Methods for treating skin pigmentation |
| 06/13/2013 | WO2013086518A1 Skin care formulation |
| 06/13/2013 | WO2013085558A1 Methods and compositions for alteration of skin pigmentation |
| 06/13/2013 | WO2013085346A1 Novel phytosphingosine derivatives, and composition comprising same for preventing and treating inflammatory skin diseases, autoimmune diseases, and hyperkeratosis diseases |
| 06/13/2013 | WO2013085017A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013085016A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013084578A1 Evaluation method, screening method, antipruritic substance, and antipruritic agent |
| 06/13/2013 | WO2013084163A1 Composition comprising a chelidonium majus extract and copaiba, and the use thereof for the treatment of cutaneous dysfunctions |
| 06/13/2013 | WO2013083695A1 Compositions for preventing or treating adverse reactions of egfr inhibition |
| 06/13/2013 | WO2013083431A1 Skin anti-ageing composition |
| 06/13/2013 | WO2013083338A1 New proteases able to hydrolyze gluten peptides and proteins at acidic ph, from the actinomycete actinoallomurus |
| 06/13/2013 | WO2013083040A1 Application of fluoxetine to treatment of depigmentation diseases |
| 06/13/2013 | WO2013056684A3 Thiazole derivative as dhodh inhibitor and use thereof |
| 06/13/2013 | WO2013032248A3 Composition for improving skin conditions, containing extracellular domain of human bone morphogenetic protein receptor 1a as active ingredient |
| 06/13/2013 | WO2013009100A3 Method for manufacturing umbilical cord extract and usage of same |
| 06/13/2013 | US20130150349 2,4-pyrimidinediamine compounds and their uses |
| 06/13/2013 | US20130149343 Hemostatic Bioabsorbable Device with Polyethylene Glycol Binder |
| 06/13/2013 | CA2877423A1 Application of fluoxetine to treatment of depigmentation diseases |
| 06/13/2013 | CA2858570A1 Methods and compositions for alteration of skin pigmentation |
| 06/13/2013 | CA2858211A1 Skin care formulation |
| 06/13/2013 | CA2858164A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | CA2857250A1 Compositions for preventing or treating adverse reactions of egfr inhibition |
| 06/13/2013 | CA2857231A1 Skin anti-ageing composition |
| 06/13/2013 | CA2852365A1 New proteases able to hydrolyze gluten peptides and proteins at acidic ph, from the actinomycete actinoallomurus |
| 06/12/2013 | EP2601965A1 Compositions for preventing or treating adverse reactions of EGFR inhibition |
| 06/12/2013 | EP2601959A1 Elastase inhibitor |
| 06/12/2013 | EP2601191A2 Compounds and compositions for mitigating tissue damage and lethality |